Carnitine deficiency is associated with late-onset hypogonadism and depression in uremic men with hemodialysis

References

• Carrero JJ, Stenvinkel P. The vulnerable man: impact of testosterone deficiency on the uraemic phenotype. Nephrol Dial Transplant 2012;27:4030–41
   Google Scholar
• Carrero JJ, Qureshi AR, Parini P, et al. Low serum testosterone increases mortality risk among male dialysis patients. J Am Soc Nephrol 2009;20:613–20
   Google Scholar
• Kyriazis J, Tzanakis I, Stylianou K, et al. Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients. Nephrol Dial Transplant 2011;26:2971–7
   Google Scholar
• Agganis BT, Weiner DE, Giang LM, et al. Depression and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis 2010;56:704–12
   PubMed Web of Science ®Google Scholar
• Cukor D, Rosenthal DS, Jindal RM, et al. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int 2009;75:1223–9
   PubMed Web of Science ®Google Scholar
• Park HC, Yoon HB, Son MJ, et al. Depression and health-related quality of life in maintenance hemodialysis patients. Clin Nephrol 2010;73:374–80
   Google Scholar
• Martiny C, de Oliveira e Silva AC, Neto JP, Nardi AE. Factors associated with risk of suicide in patients with hemodialysis. Compr Psychiatry 2011;52:465–8
   PubMed Web of Science ®Google Scholar
• Boulware LE, Liu Y, Fink NE, et al. Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality. Clin J Am Soc Nephrol 2006;1:496–504
   PubMed Web of Science ®Google Scholar
• Cano NJ, Heng AE, Pison C. Multimodal approach to malnutrition in malnourished maintenance hemodialysis patients. J Ren Nutr 2011;21:23–6
   Google Scholar
• Iglesias P, Carrero JJ, Díez JJ. Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options. J Nephrol 2012;25:31–42
   Google Scholar
• Fahed AC, Gholmieh JM, Azar ST. Connecting the lines between hypogonadism and atherosclerosis. Int J Endocrinol 2012;2012:793–953
   Google Scholar
• Afsar B. The relationship between depressive symptoms and erythropoietin resistance in stable hemodialysis patients with adequate iron stores. Int J Artif Organs 2013;36:314–9
   Google Scholar
• Chatterjee R, Wood S, McGarrigle HH, et al. A novel therapy with testosterone and sildenafil for erectile dysfunction in patients on renal dialysis or after renal transplantation. J Fam Plann Reprod Health Care 2004;30:88–90
   Google Scholar
• Francomano D, Bruzziches R, Natali M, et al. Cardiovascular effect of testosterone replacement therapy in aging male. Acta Biomed 2010;81:101–6
   PubMedGoogle Scholar
• Bøhmer T, Hoel P, Purvis K, Hansson V. Carnitine levels in human accessory sex organs. Arch Androl 1978;1:53–9
   PubMed Web of Science ®Google Scholar
• Evans AM, Fornasini G. Pharmacokinetics of L-carnitine. Clin Pharmacokinet 2003;42:941–67
   PubMed Web of Science ®Google Scholar
• Evans A. Dialysis-related carnitine disorder and levocarnitine pharmacology. Am J Kidney Dis 2003;41:S13–26
   PubMed Web of Science ®Google Scholar
• Adachi T, Fukami K, Yamagishi S, et al. Decreased serum carnitine is independently correlated with increased tissue accumulation levels of advanced glycation end products in haemodialysis patients. Nephrology (Carlton) 2012;17:689–94
   Google Scholar
• Cavallini G, Caracciolo S, Vitali G, et al. Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging. Urology 2004;63:641–6
   PubMed Web of Science ®Google Scholar
• Cruciani RA, Dvorkin E, Homel P, et al. Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II study. J Pain Symptom Manage 2006;32:551–9
   PubMed Web of Science ®Google Scholar
• Heinemann LA, Saad F, Zimmermann T, et al. The Aging Males’ Symptoms (AMS) scale: update and compilation of international versions. Health Qual Life Outcomes 2003;1:15
   PubMedGoogle Scholar
• Zung WW. A self-rating depression scale. Arch Gen Psychiatry 1965;12:63–70
   PubMed Web of Science ®Google Scholar
• Takahashi M, Ueda S, Misaki H, et al. Carnitine determination by an enzymatic cycling method with carnitine dehydrogenase. Clin Chem 1994;40:817–21
   PubMed Web of Science ®Google Scholar
• Nagano M, Fukami K, Yamagishi S, et al. Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patients. Nephrology (Carlton) 2011;16:299–303
   PubMed Web of Science ®Google Scholar
• Daugirdas JT. Linear estimates of variable-volume, single-pool Kt/V: an analysis of error. Am J Kidney Dis 1993;22:267–70
   Google Scholar
• Aydogan U, Aydogdu A, Akbulut H, et al. Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions. Endocr J 2012;59:1099–105
   PubMed Web of Science ®Google Scholar
• Zhang XW, Liu ZH, Hu XW, et al. Androgen replacement therapy improves psychological distress and health-related quality of life in late onset hypogonadism patients in Chinese population. Chin Med J (Engl) 2012;125:3806–10
   Google Scholar
• Fernandes GV, dos Santos RR, Soares W, et al. The impact of erectile dysfunction on the quality of life of men undergoing hemodialysis and its association with depression. J Sex Med 2010;7:4003–10
   PubMed Web of Science ®Google Scholar
• Cavallini G, Modenini F, Vitali G, Koverech A. Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy. Urology 2005;66:1080–5
   PubMedGoogle Scholar
• Sayed-Ahmed MM, Khattab MM, Gad MZ, Mostafa N. L-carnitine prevents the progression of atherosclerotic lesions in hypercholesterolaemic rabbits. Pharmacol Res 2001;44:235–42
   Google Scholar
• Shankar SS, Mirzamohammadi B, Walsh JP, Steinberg HO. L-carnitine may attenuate free fatty acid-induced endothelial dysfunction. Ann N Y Acad Sci 2004;1033:189–97
   Google Scholar
• Salvioli G, Neri M. L-acetylcarnitine treatment of mental decline in the elderly. Drugs Exp Clin Res 1994;20:169–76
   Google Scholar
• Bonavita E. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain. Int J Clin Pharmacol Ther Toxicol 1986;24:511–6
   PubMed Web of Science ®Google Scholar